CTOs on the Move

Supermed Inc

www.supermedinc.com

 
Supermed Inc is a Ormond Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Anatomical Chart Company

Anatomical Chart Company is a Skokie, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Apex Communications

Apex Communications is a Fairfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

XpresSpa Group

XpresSpa is the industry-leading luxury travel spa business and wholly owned subsidiary of XpresSpa Group Inc. (Nasdaq: XSPA). Serving almost one million air travelers each year at its 57 locations in the United States, Holland and the United Arab Emirates, including stores in 23 airports and 1 off-airport location at Westfield`s World Trade Center in New York City. XpresSpa offers travelers premium spa services, including massages, reflexology, stress and tension release, manicures, pedicures, facials and waxing. Its Xpres nail, massage and hair blow-out services are designed specifically for the busy traveling customer. In stores and online, XpresSpa also sells exclusive luxury travel products and accessories, including travel pillows, blankets, massagers, and personal, hair, nail and bath and body products. XpresSpa has over 750 employees, including talented teams of professionally licensed massage therapists, cosmetologists and nail technicians who are committed to providing exceptional customer experiences.

Prejuvenation Aesthetics

Prejuvenation Aesthetics is a med spa in Ashburn, VA that specializes in preventative cosmetic treatments to enhance natural facial features and boost confidence.

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.